Commentary - (2016) Volume 5, Issue 1
The Rationality to Use of Galectin-3 as Target in Biomarker-Guided Therapy of Type 2 Diabetes Mellitus
- Alexander Berezin*
- Department of Internal Medicine, State Medical University, Zaporozhye, Postcode 69035, Ukraine
*Corresponding Author:
Alexander Berezin, Department of Internal Medicine, Consultant of Therapeutic Unit, State Medical University, 26, Mayakovsky Av., Zaporozhye, Postcode 69035, Ukraine, Tel: +38 061 2894585, Fax: +38 0612894585
Email:
